Side by side
Consultation participation and their own register declarations, side by side. Counts, not judgments — participation is not influence.
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Company · Germany
Other · Belgium
Declared costs: €300K+ a year · in the register since 2012
Medicinal products for human use · A European Health Data Space · European Medicines Agency
Register facts self-declared (snapshot 2 Sept 2026); cost bands are floors. Shared files are shared attention, not evidence of coordination.
Their opening passages on the files they share, verbatim and in filing order. We do not summarize, compare, or characterize positions — read them at source.
McKesson Europe · filed 22 Apr 2021 · source
McKesson Europe fully supports the European Commission’s (EC) evaluation of the General Pharmaceutical Legislation. We strongly believe that the EU’s General Pharmaceutical Legislation is overdue a comprehensive review. The EC needs to utilize this opportunity and make General Pharmaceutical Legislation more effective for European patients.
European Respiratory Society · filed 27 Apr 2021 · source
ERS appreciates the opportunity to contribute to this roadmap on the revision of the General Pharmaceutical legislation (namely Directive 2001/83/EC1 and Regulation (EC) No 726/20042). Join the dots: Legislation must foster medical advancement not hamper it.
European Respiratory Society · filed 8 Nov 2023 · source
Answer to the request for feedback on the revision of the EU general pharmaceutical legislation The European Respiratory Society, (ERS) is one of the leading medical organisations in the respiratory field, with a growing membership spanning over 160 countries.
McKesson Europe · filed 1 Feb 2021 · source
McKesson Europe fully supports the European Commission’s initiative “Digital health data and services – the European health data space”. We would like to use this opportunity to contribute to the ongoing roadmap consultation and flag areas where EU policy action can further be improved.
European Respiratory Society · filed 3 Feb 2021 · source
The European Respiratory Society appreciates the opportunity to input to the proposal on the European Health Data Space for better healthcare, research and policy-making. The COVID-19 pandemic has clearly shown the benefits that better sharing and use of health data could bring to healthcare in the EU.
European Respiratory Society · filed 25 Jul 2022 · source
The European Respiratory Society appreciates the opportunity to give feedback to the proposal on the European Health Data Space (EHDS) for better healthcare, research and policy-making. The COVID-19 pandemic has shown the need of electronic health data for the development of policy response to health emergencies, better preparedness of healthcare services and for fostering research and innovation.
McKesson Europe · filed 1 Feb 2021 · source
McKesson Europe fully supports EMA’s extended role in addressing public health emergencies including their new role in monitoring medicine shortages. We also support EMA’s definition of medicine shortages as defined in Art. 2 / (d) of the regulation ( “shortage” means that supply of a medicinal product for human use or a medical device does not meet demand for that medicinal product or medical device”).
European Respiratory Society · filed 2 Feb 2021 · source
The European Respiratory Society appreciates the opportunity to give input to the proposal on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices.
2 organizations on one sheet: every file each filed on, their register declarations, and a working link to each submission. Free: we ask for your name and email, and PolicySpeak may contact you about the product (privacy policy). The per-file record stays downloadable without signing up on each file’s page.